Meeting
2014 Gastrointestinal Cancers Symposium
The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.
Authors
Kenji Tomizawa
Toranomon hospital, Tokyo, Japan
Kenji Tomizawa , Koichi Suyama , Yuji Miura , Akihiko Shimomura , Yutaka Hanaoka , Shigeo Toda , Jin Moriyama , Shuichiro Matoba , Toshimi Takano , Hiroya Kuroyanagi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 629)
DOI
10.1200/jco.2014.32.3_suppl.629
Abstract #
629
Poster Bd #
E20
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
A novel preoperative protocol for locally advanced rectal cancer: Hyperfractionated short-course radiotherapy combined with chemotherapy.
First Author: Hiroshi Doi
Poster
2024 ASCO Annual Meeting
GEMINI-Gastric: A phase 2 study of novel treatment combinations in patients with locally advanced unresectable or metastatic gastric cancers.
First Author: Lin Shen
Poster
2023 ASCO Annual Meeting
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
First Author: Claire Palles
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.
First Author: Akshit Chitkara